Biotech Week.  Sept 26, 2012 p733.
Full Text:COPYRIGHT 2012 NewsRX LLC

By a News Reporter-Staff News Editor at Biotech Week — Fresh data on Musculoskeletal and Neuronal Interaction are presented in a new report. According to news reporting originating from Tokyo, Japan, by NewsRx correspondents, research stated, “A randomized controlled trial was conducted to determine the effect of 6 months of whole body vibration (WBV) exercise on physical function in postmenopausal osteoporotic women treated with alendronate. Fifty-two ambulatory postmenopausal women with osteoporosis (mean age: 74.2 years, range: 51-91 years) were randomly divided into two groups: an exercise group and a control group.”

Our news editors obtained a quote from the research from the Keio University School of Medicine, “A four-minute WBV exercise was performed two days per week only in the exercise group. No exercise was performed in the control group. All the women were treated with alendronate. After 6 months of the WBV exercise, the indices for flexibility, body balance, and walking velocity were significantly improved in the exercise group compared with the control group. The exercise was safe and well tolerated. The reductions in serum alkaline phosphatase and urinary cross-linked N-terminal telopeptides of type I collagen during the 6-month period were comparable between the two groups.”

According to the news editors, the researchers concluded: “The present study showed the benefit and safety of WBV exercise for improving physical function in postmenopausal osteoporotic women treated with alendronate.”

For more information on this research see: Whole body vibration exercise improves body balance and walking velocity in postmenopausal osteoporotic women treated with alendronate: Galileo and Alendronate Intervention Trail (GAIT). Journal of Musculoskeletal and Neuronal Interactions, 2012;12(3):136-43 (see also Musculoskeletal and Neuronal Interaction).

The news editors report that additional information may be obtained by contacting J. Iwamoto, Institute for Integrated Sports Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Keywords for this news article include: Asia, Tokyo, Japan, Drugs, Therapy, Hormones, Alendronate, Diphosphonates, Bisphosphonates, Musculoskeletal and Neuronal Interaction.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC

Record Number: A304101033
Google Rank Checker